Patents by Inventor Karin Loser

Karin Loser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NDP-MSH FOR TREATMENT OF INFLAMMATORY AND/OR NEURODEGENERATIVE DISORDERS OF THE CNS
    Publication number: 20200360484
    Abstract: The present invention is related to NDP-MSH or pharmaceutically acceptable salts thereof for therapeutic and/or prophylactic therapeutic treatment of inflammatory and/or neurodegenerative disorders of the CNS or multiple sclerosis. The present invention is further related to pharmaceutical compositions and a kit comprising NDP-MSH or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: February 26, 2020
    Publication date: November 19, 2020
    Inventors: THOMAS LUGER, KARIN LOSER, SVEN MEUTH
  • NDP-MSH for treatment of inflammatory and/or neurodegenerative disorders of the central nervous system
    Patent number: 10610573
    Abstract: The present invention is related to NDP-MSH or pharmaceutically acceptable salts thereof for therapeutic and/or prophylactic therapeutic treatment of inflammatory and/or neurodegenerative disorders of the CNS or multiple sclerosis. The present invention is further related to pharmaceutical compositions and a kit comprising NDP-MSH or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: August 5, 2014
    Date of Patent: April 7, 2020
    Assignee: WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
    Inventors: Thomas A Luger, Karin Loser
  • NDP-MSH FOR TREATMENT OF INFLAMMATORY AND/OR NEURODEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM
    Publication number: 20160158322
    Abstract: The present invention is related to NDP-MSH or pharmaceutically acceptable salts thereof for therapeutic and/or prophylactic therapeutic treatment of inflammatory and/or neurodegenerative disorders of the CNS or multiple sclerosis. The present invention is further related to pharmaceutical compositions and a kit comprising NDP-MSH or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: August 5, 2014
    Publication date: June 9, 2016
    Inventors: Thomas A. LUGER, Karin LOSER
  • Use of a Compound with RANKL Activity
    Publication number: 20090162426
    Abstract: The present invention relates to the use of a compound with receptor activator of nuclear factor-kB ligand (RANKL) activity for the manufacture of a topical pharmaceutical formulation for the modulation of local or systemic Treg numbers and the treatment or the prevention of skin-associated or systemic diseases.
    Type: Application
    Filed: May 8, 2007
    Publication date: June 25, 2009
    Applicant: IMBA-INSTITUT FUR MOLEKULARE BIOTECHNOLOGIE GmbH
    Inventors: Josef Penninger, Karin Loser, Stefan Beissert